T = 293(2) K.
CCDC no.: 1561268
The crystal structure is shown in the figure. Table 1 contains details on crystal structure and measurement conditions. Table 2 lists the atoms with their coordinates and displacement parameters.
Source of materials
The title compound was synthesized according to a reported procedure [4] . A mixture of 3,5-cyclohexanedione (10 mmol), 4-bromo-benzaldehyde (10 mmol), malononitrile (10 mmol) and 4-(dimethylamino)pyridine (DMAP) (1 mmol) in ethanol (100 mL) was refluxed for 2-3 h and then cooled to room temperature. After filtering, the precipitates were sequentially *Corresponding author: Yuanyuan Yu, Department of Chemistry and Chemical Engineering, Shaanxi Xueqian Normal University, Xi'an, China, e-mail: yuyuanyuan3157@126.com washed with ice-cooled water and ethanol and then dried under vacuum.
Experimental details
All H atoms were modelled at their calculated positions and refined via the riding model. The U iso of H-atoms were constrained to 1.2 times Ueq of their bonding atoms.
Comment
The chemistry and diverse applications of organic heterocyclic derivatives have received much attention due to their pronounced biological activity [5] [6] [7] [8] . For example, pyrans are well known to exhibit anti-HIV PR inhibitors, anti breast cancer, anti-inflammatory, anti-protozoal, antitumor, antitubercular with antimycobacterial activity. In the crystal structure of the title compound, the newly formed pyran ring is essentially planar and perpendicular to the bromophenyl ring.
The amino group donates two hydrogen bonds, to the cyano and oxo groups, repespectively, with the following parameters: D· · · A 3.122(4) Å and D-H· · · A 176.76°for N1. . .N2 and D· · · A 2.983(4) Å and D-H· · · A 146.52°for N1. . .O2; the former is involved in the formation of a centrosymmetric H-bonded dimer.
